| Browse All

Alpha Teknova, Inc. (TKNO)

Healthcare | Drug Manufacturers - Specialty & Generic | Hollister, United States | NasdaqGM
2.93 USD +0.25 (9.328%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 2.93

Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 2:47 p.m. EDT

TKNO is currently trading near its 52-week low with a negative forward P/E and profit margins, indicating weak earnings performance. The recent news highlights analyst optimism and insider buying, which could signal potential for a rebound. However, the stock's high debt-to-equity ratio and negative cash flow raise concerns about its financial health. While the options data hints at potential for upward movement, the lack of dividends and weak fundamentals make it a risky short-term play.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.167255
AutoARIMA0.212767
AutoETS0.212768
AutoTheta0.236922

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 80%
H-stat 0.03
Ljung-Box p 0.000
Jarque-Bera p 0.126
Excess Kurtosis -1.43
Attribute Value
Sector Healthcare
Debt to Equity Ratio 41.104
Revenue per Share 0.758
Market Cap 157,011,856
Forward P/E -7.51
Beta 0.33
Profit Margins -42.59%
Website https://www.teknova.com

As of April 11, 2026, 2:47 p.m. EDT: Options activity suggests a mixed sentiment. For the near-term expirations, there is a concentration of activity on the call side with higher IV on the 2026-06-18 expiration, indicating potential for significant upward movement. However, the puts show limited activity, which may suggest limited bearish sentiment. The overall options data indicates a potential for volatility with a focus on higher strike prices, suggesting that speculators may be anticipating a rise in the stock price.


Info Dump

Attribute Value
52 Week Change -0.5363322
Address1 2,451 Bert Dr.
All Time High 30.89
All Time Low 1.155
Ask 3.04
Ask Size 1
Audit Risk 4
Average Analyst Rating 1.7 - Buy
Average Daily Volume10 Day 147,390
Average Daily Volume3 Month 221,403
Average Volume 221,403
Average Volume10Days 147,390
Beta 0.33
Bid 2.84
Bid Size 1
Board Risk 10
Book Value 1.284
City Hollister
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 7
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.93
Current Ratio 4.579
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 2.96
Day Low 2.7
Debt To Equity 41.104
Display Name Alpha Teknova
Earnings Call Timestamp End 1,772,145,000
Earnings Call Timestamp Start 1,772,145,000
Earnings Timestamp 1,778,097,600
Earnings Timestamp End 1,778,097,600
Earnings Timestamp Start 1,778,097,600
Ebitda -10,134,000
Ebitda Margins -0.25010002
Enterprise To Ebitda -16.178
Enterprise To Revenue 4.046
Enterprise Value 163,942,848
Eps Forward -0.39
Eps Trailing Twelve Months -0.35
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.5513
Fifty Day Average Change 0.37870002
Fifty Day Average Change Percent 0.14843413
Fifty Two Week Change Percent -53.63322
Fifty Two Week High 7.48
Fifty Two Week High Change -4.55
Fifty Two Week High Change Percent -0.60828876
Fifty Two Week Low 1.91
Fifty Two Week Low Change 1.0200001
Fifty Two Week Low Change Percent 0.53403145
Fifty Two Week Range 1.91 - 7.48
Financial Currency USD
First Trade Date Milliseconds 1,624,627,800,000
Float Shares 10,333,309
Forward Eps -0.39
Forward P E -7.512821
Free Cashflow -2,396,250
Full Exchange Name NasdaqGM
Full Time Employees 158
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.33171
Gross Profits 13,441,000
Has Pre Post Market Data 1
Held Percent Insiders 0.10804
Held Percent Institutions 0.83622
Implied Shares Outstanding 53,587,662
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ipo Expected Date 2,021-06-25
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Long Name Alpha Teknova, Inc.
Market us_market
Market Cap 157,011,856
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_116531601
Most Recent Quarter 1,767,139,200
Net Income To Common -17,259,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 143,346,995
Number Of Analyst Opinions 3
Open 2.75
Operating Cashflow -8,646,000
Operating Margins -0.41155997
Overall Risk 9
Payout Ratio 0.0
Phone 831 637 1100
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 2.93
Post Market Time 1,776,456,246
Previous Close 2.68
Price Hint 4
Price To Book 2.2819314
Price To Sales Trailing12 Months 3.8749225
Profit Margins -0.42594
Quick Ratio 3.444
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.66667
Region US
Regular Market Change 0.25
Regular Market Change Percent 9.32836
Regular Market Day High 2.96
Regular Market Day Low 2.7
Regular Market Day Range 2.7 - 2.96
Regular Market Open 2.75
Regular Market Previous Close 2.68
Regular Market Price 2.93
Regular Market Time 1,776,456,000
Regular Market Volume 100,214
Return On Assets -0.09262
Return On Equity -0.22834
Revenue Growth 0.078
Revenue Per Share 0.758
Sand P52 Week Change 0.36506534
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 6
Shares Outstanding 53,587,662
Shares Percent Shares Out 0.0252
Shares Short 1,348,831
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 1,406,151
Short Name Alpha Teknova, Inc.
Short Percent Of Float 0.114700004
Short Ratio 9.86
Source Interval 15
State CA
Symbol TKNO
Target High Price 12.0
Target Low Price 7.0
Target Mean Price 9.0
Target Median Price 8.0
Total Cash 21,338,000
Total Cash Per Share 0.398
Total Debt 28,269,000
Total Revenue 40,520,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.35
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.0803
Two Hundred Day Average Change -1.1502998
Two Hundred Day Average Change Percent -0.28191552
Type Disp Equity
Volume 100,214
Website https://www.teknova.com
Zip 95,023